Skip to content

A survey of thyroid hormone levels during pregnancy in the city of Shijiazhuang: a self longitudinal serial study

A survey of thyroid hormone levels during pregnancy in the city of Shijiazhuang: cooperated by department of Endocrinology-Obstetrics, Second Hospital of Hebei Medical University

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042172
Enrollment
Unknown
Registered
2021-01-14
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid hormone levels in normal pregnant women

Interventions

Non-pregnant control group:Nil

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) No personal history and family history of thyroid disease; (2) No history of taking drugs that affect thyroid function (except estrogen); (3) No visible or palpable goiter; (4) Single birth; (5) No history of adverse pregnancy outcomes such as premature birth or spontaneous abortion or fetal arrest, neonatal malformations, macrosomia, etc. and history of fetal abnormalities, no obstetric complications such as pregnancy-induced hypertension, gestational diabetes, etc.; (6) No chronic diseases, such as autoimmune diseases, heart disease Vascular disease, pituitary disease, kidney disease, etc. or other major diseases; (7) No history of radiation in the head and neck; (8) Using iodized salt; (9) Living in this city for more than 5 years.

Exclusion criteria

Exclusion criteria: Those who found thyroid nodules or other thyroid diseases, serum TSH, FT4, TT4, FT3 and TT3, TPOAb, TgAb, and TRAb were beyond the normal range during the initial screening.

Design outcomes

Primary

MeasureTime frame
Thyroid peroxidase antibody;Thyroglobulin antibody;Thyroid Stimulating Hormone Receptor Antibody;Thyroid Stimulating Hormone;Triiodothyronine;Tetraiodothyronine;Serum free triiodothyronine;Serum free thyroxine;

Countries

China

Contacts

Public ContactLihui Zhang

The Second Hospital of Hebei Medical University

zhanglihui10510@163.com+86 15803210962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026